Sudair Pharma was proudly featured in the sixth edition of the National Local Content Report, issued by the Local Content and Government Procurement Authority (LCGPA). The report highlights distinguished achievements across public and private sectors in advancing local content within major national projects.
The inclusion of Sudair Pharma in the report reflects its growing role in strengthening the Kingdom’s pharmaceutical manufacturing capabilities and contributing to national self-sufficiency in critical medicines.
The report showcases Sudair Pharma’s localization initiatives across a range of essential and specialized products, which support the strategic goals of Saudi Vision 2030.
Key highlights from Sudair Pharma’s contribution include:
Manufacturing and localizing several high-impact pharmaceutical products,
Developing advanced production capacities aligned with international quality standards,
Supporting national health security through locally produced medicines,
Contributing to economic diversification and industrial growth.
Sudair Pharma expressed pride in its inclusion in the national report, reaffirming its commitment to enhancing pharmaceutical localization, expanding production capabilities, and continuing its role as a key national manufacturer in the healthcare sector.
